These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Histone deacetylase 8 suppresses osteogenic differentiation of bone marrow stromal cells by inhibiting histone H3K9 acetylation and RUNX2 activity. Fu Y, Zhang P, Ge J, Cheng J, Dong W, Yuan H, Du Y, Yang M, Sun R, Jiang H. Int J Biochem Cell Biol; 2014 Sep; 54():68-77. PubMed ID: 25019367 [Abstract] [Full Text] [Related]
9. Histone deacetylase inhibitors promote neurosteroid-mediated cell differentiation and enhance serotonin-stimulated brain-derived neurotrophic factor gene expression in rat C6 glioma cells. Morita K, Gotohda T, Arimochi H, Lee MS, Her S. J Neurosci Res; 2009 Aug 15; 87(11):2608-14. PubMed ID: 19360904 [Abstract] [Full Text] [Related]
10. Multiple Molecular pathways explain the anti-proliferative effect of valproic acid on prostate cancer cells in vitro and in vivo. Shabbeer S, Kortenhorst MS, Kachhap S, Galloway N, Rodriguez R, Carducci MA. Prostate; 2007 Jul 01; 67(10):1099-110. PubMed ID: 17477369 [Abstract] [Full Text] [Related]
11. Teratogenic effects mediated by inhibition of histone deacetylases: evidence from quantitative structure activity relationships of 20 valproic acid derivatives. Eikel D, Lampen A, Nau H. Chem Res Toxicol; 2006 Feb 01; 19(2):272-8. PubMed ID: 16485903 [Abstract] [Full Text] [Related]
12. The histone deacetylase inhibitors suberoylanilide hydroxamic (Vorinostat) and valproic acid induce irreversible and MDR1-independent resistance in human colon cancer cells. Fedier A, Dedes KJ, Imesch P, Von Bueren AO, Fink D. Int J Oncol; 2007 Sep 01; 31(3):633-41. PubMed ID: 17671692 [Abstract] [Full Text] [Related]
13. Regulation of mesenchymal stem cell and chondrocyte differentiation by MIA. Tscheudschilsuren G, Bosserhoff AK, Schlegel J, Vollmer D, Anton A, Alt V, Schnettler R, Brandt J, Proetzel G. Exp Cell Res; 2006 Jan 01; 312(1):63-72. PubMed ID: 16256983 [Abstract] [Full Text] [Related]
15. The role of noggin in human mesenchymal stem cell differentiation. Rifas L. J Cell Biochem; 2007 Mar 01; 100(4):824-34. PubMed ID: 17133353 [Abstract] [Full Text] [Related]
16. A novel collagen-binding peptide promotes osteogenic differentiation via Ca2+/calmodulin-dependent protein kinase II/ERK/AP-1 signaling pathway in human bone marrow-derived mesenchymal stem cells. Shin MK, Kim MK, Bae YS, Jo I, Lee SJ, Chung CP, Park YJ, Min do S. Cell Signal; 2008 Apr 01; 20(4):613-24. PubMed ID: 18248957 [Abstract] [Full Text] [Related]
17. Effects of overexpression of basic helix-loop-helix transcription factor Dec1 on osteogenic and adipogenic differentiation of mesenchymal stem cells. Iwata T, Kawamoto T, Sasabe E, Miyazaki K, Fujimoto K, Noshiro M, Kurihara H, Kato Y. Eur J Cell Biol; 2006 May 01; 85(5):423-31. PubMed ID: 16487626 [Abstract] [Full Text] [Related]
18. Inhibition of histone deacetylase enhances the anti-proliferative action of antiestrogens on breast cancer cells and blocks tamoxifen-induced proliferation of uterine cells. Hodges-Gallagher L, Valentine CD, Bader SE, Kushner PJ. Breast Cancer Res Treat; 2007 Nov 01; 105(3):297-309. PubMed ID: 17186358 [Abstract] [Full Text] [Related]
19. Expressional changes after histone deacetylase inhibition by valproic acid in LNCaP human prostate cancer cells. Thelen P, Schweyer S, Hemmerlein B, Wuttke W, Seseke F, Ringert RH. Int J Oncol; 2004 Jan 01; 24(1):25-31. PubMed ID: 14654937 [Abstract] [Full Text] [Related]
20. Chemical and genetic blockade of HDACs enhances osteogenic differentiation of human adipose tissue-derived stem cells by oppositely affecting osteogenic and adipogenic transcription factors. Maroni P, Brini AT, Arrigoni E, de Girolamo L, Niada S, Matteucci E, Bendinelli P, Desiderio MA. Biochem Biophys Res Commun; 2012 Nov 16; 428(2):271-7. PubMed ID: 23085045 [Abstract] [Full Text] [Related] Page: [Next] [New Search]